MINI FUTURE LONG - MERCK & CO. | Market Closed - Boerse Frankfurt Warrants 20:50:32 02/07/2024 BST | ||
| 5.25 EUR | -0.94% |
|
| Current month | +1.16% | ||
| 1 month | +4.40% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 02/07/24 | 5.22 | -1.51% |
| 01/07/24 | 5.3 | +2.71% |
| 28/06/24 | 5.16 | -5.49% |
| 27/06/24 | 5.46 | -3.53% |
| 26/06/24 | 5.66 | -1.39% |
Real-time Boerse Frankfurt Warrants
Last update July 02, 2024 at 08:50 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
BNP Paribas
|
| WKN | PH2F1Z |
| ISIN | DE000PH2F1Z5 |
| Date issued | 08/06/2021 |
| Strike | 71.39 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.89 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.9 € |
|---|---|
| Lowest since issue | 0.66 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
127.7
USD
Average target price
142.7
USD
Spread / Average Target
+11.71%
- Stock Market
- Certificates
- Certificat
